|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/51 | |
| A61P 35/00 |
| (11) | Patento numeris | 3344251 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16774458.0 |
| Europos patento paraiškos padavimo data | 2016-09-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-07-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-04-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2016/070888 |
| Data | 2016-09-05 |
| (87) | Numeris | WO 2017/037298 |
| Data | 2017-03-09 |
| (30) | Numeris | Data | Šalis |
| 201515716 | 2015-09-04 | GB | |
| 201515712 | 2015-09-04 | GB | |
| 201515714 | 2015-09-04 | GB | |
| 201515718 | 2015-09-04 | GB | |
| 201562217346 P | 2015-09-11 | US | |
| 201562217332 P | 2015-09-11 | US | |
| 201605583 | 2016-04-01 | GB | |
| 201608660 | 2016-05-17 | GB |
| (72) |
LINDMARK, Bertil, SG
OOI, Lisa, SG
|
| (73) |
Aslan Pharmaceuticals PTE Limited,
10-A Bukit Pasoh Road, 089824,
SG
|
| (54) | A COMBINATION THERAPY COMPRISING VARLITINIB AND AN ANTICANCER AGENT |
| A COMBINATION THERAPY COMPRISING VARLITINIB AND AN ANTICANCER AGENT |